...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: There is hope for us
Reply New Message
Back To Forum List View

This morning at the JP Morgan conference Celgene announced that they were buying Impact Biomedicines(private) for as much as $7 billion. This is a CVR type deal where Impact would get $1.1 billion up front, $1.4 billion of milestone payments and up to a maximum of $4.5 billion of sales milestones. This deal was done for a cast off cancer drug from Sanofi, fedratinib.

Yes these deals can happen long before phase  III trials are complete.

dyodd

tada

8 Recommendations
Re: There is hope for us
1
Toinv
Jan 09, 2018 08:26AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply